Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Case Report: Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Alexopoulou E   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 19, Iss. 6, 2009-12 ,pp. : 789-795

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

By Friedler Shevach   Gilboa Sarit   Schachter Morey   Raziel Arieh   Strassburger Devorah   Ron El Raphael  

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 27-32

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Beneficial effects of GnRH agonist administration prior to ovarian stimulation for patients with a short follicular phase

By Cédrin-Durnerin I   Bstandig B   Galey J   Bry-Gauillard H   Massin N   Hugues J-N  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 179-184

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols

By Orvieto Raoul   Rabinson Jacob   Meltzer Simion   Zohav Efraim   Anteby Eyal   Homburg Roy  

Reproductive BioMedicine Online, Vol. 13, Iss. 2, 2006-08 ,pp. : 198-201

Reproductive Healthcare Ltd

Access to resources Recommend Favorite